Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | KDM4A | O75164 | 1/20 | 0.50 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL985564 | 0.92 | ASAH1 (0.54) | POLBKDM4AASAH1MTNR1AMTNR1B | |
| SCHEMBL988168 | 0.91 | NAAA (0.59) | POLBKDM4AASAH1NAAACYP3A4 | |
| SCHEMBL988509 | 0.90 | ASAH1 (0.51) | POLBKDM4AASAH1MTNR1AMTNR1B | |
| SCHEMBL989842 | 0.87 | ASAH1 (0.51) | POLBKDM4AASAH1MTNR1AMTNR1B | |
| SCHEMBL27094297 | 0.82 | ASAH1 (0.52) | ASAH1MTNR1AMTNR1BCYP3A4CYP2C19 | |
| SCHEMBL987677 | 0.82 | ASAH1 (0.52) | ASAH1MTNR1AMTNR1BCYP3A4CYP2C19 | |
| SCHEMBL4986585 | 0.76 | ASAH1 (0.55) | ASAH1MTNR1AMTNR1BCYP3A4CYP2C19 | |
| SCHEMBL6443377 | 0.75 | CTSK (0.55) | — | |
| SCHEMBL6443393 | 0.75 | CTSK (0.43) | POLBKDM4AASAH1CYP3A4CYP2C19 | |
| SCHEMBL6432979 | 0.75 | CNR1 (0.69) | CYP3A4CYP2C19CYP2D6MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4322935-A1 | AMIDE DERIVATIVES OF BUTYRIC ACID FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION | Rhea Innovations S.R.L. (IT) | 2024-02-21 | — | — | EP | claimed |
| WO-2022219020-A1 | AMIDE DERIVATIVES OF BUTYRIC ACID FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION | RHEA INNOVATIONS S.R.L. (IT) | 2022-10-20 | — | — | WO | claimed |
| EP-2268605-A1 | FATTY ACID DERIVATIVES FOR ORAL ADMINISTRATION ENDOWED WITH HIGH PAIA- TABILITY | Berni Canani, Roberto (IT) | 2011-01-05 | — | — | EP | claimed |
| WO-2009130735-A1 | FATTY ACID DERIVATIVES FOR ORAL ADMINISTRATION ENDOWED WITH HIGH PALATABILITY | BERNI CANANI ROBERTO (IT) | 2009-10-29 | — | — | WO | claimed |
| EP-4322935-A1 | AMIDE DERIVATIVES OF BUTYRIC ACID FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION | Rhea Innovations S.R.L. (IT) | 2024-02-21 | — | — | EP | disclosed |
| WO-2022219020-A1 | AMIDE DERIVATIVES OF BUTYRIC ACID FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION | RHEA INNOVATIONS S.R.L. (IT) | 2022-10-20 | — | — | WO | disclosed |